New Horizon launches $263m Hong Kong listing

Jonathan Breen

February 04, 2021 12:00 pm

biotech_microscope_drug_production_adobe_575x375_oct13 — Medical science laboratory. Concept of virus research | Alphaspirit/alphaspirit - stock.adobe.com

New Horizon Health hit the equities market on Thursday, aiming to raise up to HK$2.04bn ($263.1m) from its IPO, according to a source familiar with the matter.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs UBS Equity China Hong Kong SAR Asia Greater China Haitong Securities Northeast Asia Asia Pacific Emerging Markets Goldman Sachs Daiwa Securities

JB

Jonathan Breen

Equities editor GlobalCapital Asia